ALHAMBRA, Calif., Jan. 4, 2022 /PRNewswire/ -- Apollo Medical
Holdings, Inc. ("ApolloMed," and together with its subsidiaries and
affiliated entities, the "Company") (NASDAQ: AMEH), a leading
physician-centric, technology-powered healthcare company focused on
enabling providers in the successful delivery of value-based care,
today announced that Brandon Sim,
Co-Chief Executive Officer, is scheduled to present virtually at
the 40th Annual J.P. Morgan Healthcare Conference on
Wednesday, January 12, 2022, at
10:30 a.m. PT/1:30 p.m. ET. The live webcast of the
presentation can be accessed at the "Events" page of the Company's
website: https://www.apollomed.net/news-media/events. A recording
will be made available shortly after the live virtual
presentation.
Management will also be participating in virtual one-on-one
meetings at the event. Those interested in meeting with management
may contact ApolloMed's Investor Relations representatives listed
below.
About Apollo Medical Holdings, Inc.
ApolloMed
is a leading physician-centric, technology-powered, risk-bearing
healthcare company. Leveraging its proprietary end-to-end
technology solutions, ApolloMed operates an integrated healthcare
delivery platform that enables providers to successfully
participate in value-based care arrangements, thus empowering them
to deliver high quality care to patients in a cost-effective
manner.
Headquartered in Alhambra,
California, ApolloMed's subsidiaries and affiliates include
management services organizations (MSOs), affiliated independent
practice associations (IPAs), and a Next Generation Accountable
Care Organization (NGACO). For more information, please visit
www.apollomed.net.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor
Relations
(626) 943-6491
investors@apollomed.net
Carolyne Sohn, The Equity
Group
(415) 568-2255
csohn@equityny.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-to-present-at-40th-annual-jp-morgan-healthcare-conference-301453122.html
SOURCE Apollo Medical Holdings, Inc.